Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…
From - Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
From - Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…